Targeted immunotherapy could boost radiotherapy response

(Institute of Cancer Research) Profiling the 'immune landscape' of patient's tumours reveals who will most benefit from radiotherapy with potential immunotherapy in bowel cancer. Effectiveness of radiotherapy depends on the level of inflammation in tumors, before and after treatment. Tumors which are chronically Inflamed before treatment could be made more susceptible using targeted immunotherapies.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news